ML4 Foundation

Mucolipidosis Type IV:
A Devastating Genetic Disease

Mucolipidosis Type IV (ML4), was first identified in 1974 as a genetic disease. Children with ML4 begin to exhibit developmental delay during the first year of life. Many parents seek opthomalogic evaluations for pseudo-strabismus and medical intervention for delayed motor milestones. Children with ML4 typically reach a maximum developmental age of 18 months in language and motor function, although their receptive abilities are more advanced.Read more

We all "Do" every single day. Whether we read a book, go to the gym, play golf, clean the garage or take a nap, we are always "Doing" So, what better way to raise money to help find a cure for ML4 than to "Do for ML4"? Join us in raising money for medical research and create your own fundraiser centered around the things you already "Do". It’s easy and fun to ask your friends to support you while you "Do For ML4"!

Randy Gold, ML4 Foundation Vice President, was named the 2011 Jewish Community Hero sponsored by the Jewish Federations® of North America for his efforts around promoting awareness of the 19 known preventable Jewish Genetic Diseases.

Mucolipidosis IV Foundation